6 July 2017 EMA/551661/2016 version 2 Information Management Division

SPOR data management services - high level changes

Table of contents 1. Introduction ............................................................................................ 2 2. New solutions for access and use of SPOR data....................................... 2 2.1. RMS backward compatibility .................................................................................. 2 2.2. RMS and OMS business services ............................................................................. 3

3. Data stewards ......................................................................................... 3 4. Data content ............................................................................................ 4 4.1. Referentials List release plan ................................................................................. 4 4.2. Content of the OMS dictionary ............................................................................... 4

5. RMS and OMS operating models .............................................................. 4 5.1. Key features of the OMS and RMS operating models ................................................. 5

6. Data management ................................................................................... 5 7. EMA IT Service Desk ................................................................................ 6

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

1. Introduction RMS (Referentials Management Services) and OMS (Organisations Management Services) are the first two projects to be delivered as part of the phased implementation of SPOR and are key enablers of the implementation of ISO IDMP in the EU. The introduction of RMS and OMS will bring a number of key changes that can be classified as follows: •

New solutions providing access to SPOR data;



Data stewards managing SPOR data;



Data content to support ISO IDMP implementation;



New RMS and OMS operating models;



Ongoing data management activities;



IT Service desk to support stakeholders.

The impact of these changes will be experienced in different ways by Human and by Veterinary National Competent Authorities (NCAs) and by industry due to the variety in size, infrastructure and complexity of systems and processes within these organisations. NCAs and industry therefore need to understand what is changing centrally and then draw up implementation plans based on how they determine the changes will specifically impact their own organisation. At RMS and OMS go-live, submission processes will continue as before and there will be no immediate process changes for stakeholders. Some changes in the current submission processes are being explored and consultation is taking place with stakeholders on these. More information will be provided in due course to explain any applicable process changes and timings.

2. New solutions for access and use of SPOR data Stakeholders will be able to access and use the data within RMS and OMS via two methods: •

SPOR web interfaces – reached via a portal. The SPOR web interfaces will provide a user-friendly (human to system) means of exploiting the business services of the web-based RMS and OMS applications;



SPOR APIs (Application Programming Interface) – a set of programming instructions and standards that organisations may choose to use to integrate with their local systems (system to system) in order to exploit the business services of the web-based RMS and OMS applications. The APIs can also be configured to manage automated data synchronisation.

2.1. RMS backward compatibility At RMS go-live, NCAs that currently use EUTCT (EU Telematics Controlled Terms) via the web user interface will find that they can still view Substances Lists but no longer view the Referentials Lists that were housed in EUTCT. However, those NCAs that currently use the EUTCT API will still be able to access the Referentials Lists that were in EUTCT due to the built-in backward compatibility. If users want to be able to view a complete set of Referentials Lists, i.e. those that include both Lists that were housed in EUTCT in addition to any new Lists, they will need to adopt the RMS API or RMS web user interface.

SPOR data management services - high level changes EMA/551661/2016

Page 2/6

Table 1. RMS backward compatibility EUTCT web user

Backwards

RMS web user

interface

compatible EUTCT

interface

RMS API

API Can only access

Can access Substances

Cannot access

Cannot access

Substances Lists

Lists

Substances Lists

Substances Lists

Unable to see

Can access Referentials

Can access all

Can access all

Referentials Lists, which

Lists, which will have

Referentials Lists in

Referentials Lists in

will have been migrated

been migrated to RMS

RMS (former EUTCT

RMS (former EUTCT

Lists plus new Lists)

Lists plus new Lists)

to RMS

EUTCT is publicly available to NCAs, industry and any user for browsing but only NCAs can download the data and request changes to the data.

2.2. RMS and OMS business services RMS and OMS will offer a number of services and functionality, shown in the diagram below. All services will be available to all users with the exception of publishing documents which is only available to EMA and Term translations which are only available to NCAs. Figure 1. RMS and OMS business services

3. Data stewards Data stewards will be a specialised team of EMA staff that will manage the data (Referentials and Organisations initially). The overall objective of data stewards will be to apply consistent data quality

SPOR data management services - high level changes EMA/551661/2016

Page 3/6

rules and standards. They will be responsible for validating access requests to SPOR data management services and for taking action on change requests for new/updated Referentials Lists/Terms and Organisations data. Data stewards will also be responsible to provide user support.

4. Data content The introduction of structured RMS and OMS data accompanied by unique IDs will support the implementation of ISO IDMP standards.

4.1. Referentials List release plan Referentials data will become available in RMS in phases over time. At go-live, the following Lists will be published: •

Lists from EUTCT (e.g. shelf life type, target species);



New Lists to support OMS (e.g. party classification);



New Lists to support PMS (e.g. material);



Updated Lists for ISO 11239 (pharmaceutical dose form, routes of administration and packaging) and ISO 11240 (units of measurement).These Lists exist in EUTCT in a very flat structure and at go-live they will be structured with full ISO data elements.

Referentials data will subsequently be expanded with Lists to support ISO standards for products and substances: ISO 11238 – Referential data to support substance registration and ISO 11615 – Referential data to support products. Further Lists can also be added in the future upon request.

4.2. Content of the OMS dictionary 1 The initial content of the dictionary at go-live will be: •

Regulatory Authorities/National Competent Authorities (NCAs).

Data content will be added incrementally to the dictionary as part of maintenance work and by Q3 2017 the following data will also be included: •

Marketing Authorisation Holders (MAHs): Human (H) + Veterinary (V) Centrally Authorised Products (CAPs) and Human (H) Nationally Authorised Products (NAPs);



Marketing Authorisation Applicants (MAAs): (H+V) CAPs;



Maximum Residue Limit (MRL) applicants (Veterinary).

Additional Organisation data will then be published by the following stages: •

Q4 2017: Sponsors (H) CAPS & NAPs;



Q1 2018: Manufacturers: (H+V) CAPs;



Q3 2018: Manufacturers: (H+V) NAPs.

Further Organisation data will be published in the future and the prioritisation of its inclusion, in the dictionary, will be defined at a later stage: • 1

Veterinary MAHs for NAPs; Section 4.2 was updated to reflected current OMS data release plan

SPOR data management services - high level changes EMA/551661/2016

Page 4/6



Contract Research Organisations (CROs);



Clinical trials sites;



Academia;



Hospitals;



Wholesale distributers;



MAA/MAH and manufacturers in the context of herbal and homeopathic medicinal products or compassionate use medicinal products;



QPPV (Qualified Person for Pharmacovigilance).

EMA will communicate in advance to stakeholders about the timing of the release of new Organisation data in the dictionary and specify when industry can start submitting change requests for the Organisation data.

5. RMS and OMS operating models EMA will act as a broker by making available a single source of centrally-provided master data and accompanying data management services to NCAs, EMA itself, industry and other external stakeholders. These data management services will be supported by standard processes, also referred to as operating models, which will enable a more efficient and consistent way of managing data.

5.1. Key features of the OMS and RMS operating models •

Common process for industry to pre-register/update Organisations and Referentials data before submitting regulatory applications;



Establishment of a centralised dictionary of Organisations and Lists of Referentials to be used as a reference for, and in support of, EU regulatory activities;



Data validated by EMA data stewards and made available in a structured format in line with ISO/EU standards;



Validated, re-usable, quality data;



A system to generate and maintain Organisation IDs and Referential IDs for use in regulatory submissions from across EMA, industry and NCAs;



Common API interface for exchange of Referentials and Organisations data.

6. Data management In order to reflect changes/updates in SPOR data in their local systems, NCAs and industry may need to enhance their local data to align with ISO/EU data formats within RMS and OMS in the following ways: •

Data transformation – change the data structure, e.g. split data fields;



Data enrichment – complete the set of data, e.g. add a new field such as post code;



Data mapping – where there is a need to maintain local data, e.g. local controlled vocabularies, mapping may be required between local data and central SPOR data to produce outputs in line with ISO/EU terminology and formats.

SPOR data management services - high level changes EMA/551661/2016

Page 5/6

NCAs and industry will also need to synchronise or maintain mappings in their local systems with RMS and OMS on an ongoing basis in order to ensure they are using the correct data in regulatory submissions. They may choose to make use of the RMS and OMS web APIs to support them in automating the synchronisation of data or in the maintenance of the mapping of the data.

7. EMA IT Service Desk The EMA IT Service Desk will provide technical support for SPOR data management services for all stakeholders. More information will be provided nearer to RMS and OMS go-live, such as contact details and the specific help that will be on offer.

SPOR data management services - high level changes EMA/551661/2016

Page 6/6

SPOR data management services - European Medicines Agency

6 July 2017. EMA/551661/2016 version 2 .... SPOR data management services - high level changes. EMA/551661/2016. Page 2/6 ... Lists plus new Lists).

367KB Sizes 3 Downloads 261 Views

Recommend Documents

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - 6. REST Services for details). Authentication will be HTTP Basic Authentication ...... attributes plus optional details of associated documents and ...

Agenda - Data anonymisation workshop - European Medicines Agency
Nov 30, 2017 - broader set of data which ensure privacy protection and meet the standards required to maintain ... To understand the legislation impacting clinical data sharing across two jurisdictions, drawing out differences and .... healthcare dat

SPOR webinar: Using OMS & RMS data in eAF - European Medicines ...
3 days ago - Org B. Loc 1. Loc 2. Loc 3. Loc 4. Org_ID_B. Org_ID_A. Loc_ID_1. Loc_ID_2. Loc_ID_3. Loc_ID_4. DE. UK. Note: Org A name can be the same as Org B name ..... MS m ile s to n e s. eAF integration with OMS (already integrated with RMS). MA a

Data Quality Control methodology - European Medicines Agency
Page 3/26. 1. Purpose. The purpose of this document is to describe the data quality framework for Article 57(2) data. The data quality framework for Article 57(2) data ..... Data analysis. Regulatory actions and legal obligation. Communication with s

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

EU Telematics Management Board - European Medicines Agency
EU Telematics Management Board - European Medicines Agencyfeedproxy.google.com/~r/EmaUpdates/~3/UOZtMxO1_G4/open_document.jsp

CVMP Risk Management Strategy - European Medicines Agency
Feb 16, 2017 - Scientific data exist that demonstrate replication competent RD114 ... A risk assessment consists of the identification of hazards and the analysis and evaluation of risks ...... interpretation of a positive signal maybe equivocal.

CVMP Risk Management Strategy - European Medicines Agency
Feb 16, 2017 - An agency of the European Union. Telephone +44 ... European Medicines Agency, 2017. ...... Jin-Hoi Kim, Jae-Wook Oh, Kunho Seo. Virology ...

European Union Network data board - European Medicines Agency
Sep 21, 2016 - EMA/231985/2016. European Union Network Data Board. Terms of Reference. 1. Remit, vision and mission. The European Union Network Data Board (EUNDB) is an advisory body co-chaired by the Head of. Business Data and Support Department (EM

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.